Cosciens Biopharma Inc (CSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 08-1992 | 05-1992 | 02-1992 | 08-1991 | 08-1990 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 7,807 | 7,104 | 5,088 | 4,193 | 0 |
| TOTAL | $7,807 | $7,104 | $5,088 | $4,193 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,721 | 1,798 | 1,691 | N/A | N/A |
| Other Non-Current Assets | 6,815 | 7,013 | 7,063 | 7,061 | 0 |
| TOTAL | $8,536 | $8,811 | $8,753 | $7,061 | $N/A |
| Total Assets | $16,343 | $15,915 | $13,841 | $11,254 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 822 | 1,048 | 686 | 514 | N/A |
| Accounts payable and accrued liabilities | 2,220 | 2,408 | 2,064 | 1,027 | 0 |
| Accrued Expenses | 553 | 824 | 674 | 1,113 | N/A |
| Other current liabilities | 12 | 287 | 72 | 126 | N/A |
| TOTAL | $3,662 | $5,058 | $3,798 | $3,841 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $4 | $4 | $4 | $4 | $N/A |
| Total Liabilities | $3,666 | $5,062 | $3,801 | $3,845 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 53 | 77 | 77 | 38 | N/A |
| TOTAL | $9,502 | $3,300 | $3,300 | $3,300 | $N/A |
| Total Liabilities And Equity | $13,168 | $8,362 | $7,101 | $7,145 | $0 |